Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

33.43 +0.67 (+2.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	791,544
Open	33.44
Bid (Size)	33.43 (100)
Ask (Size)	33.45 (200)
Prev. Close	32.76
Today's Range	33.33 - 33.94
52wk Range	23.23 - 50.79
Shares Outstanding	32,250,236
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Value Stock on Our Buy List and 2 Facing Headwinds

April 06, 2026

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Via StockStory

GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know

April 02, 2026

What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa...

Via StockStory

Performance

YTD	-26.6%	-26.6%
1 Month	-10.3%	-10.3%
3 Month	-27.7%	-27.7%
6 Month	+0.1%	+0.1%
1 Year	+22.1%	+22.1%

More News

2 Profitable Stocks to Consider Right Now and 1 We Question

April 02, 2026

Via StockStory

Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD ↗

March 30, 2026

Via The Motley Fool

Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case ↗

March 28, 2026

Via Chartmill

Collegium Pharmaceutical Inc (NASDAQ:COLL) Reports Q4 Revenue Growth but Misses Earnings Estimates ↗

February 26, 2026

Via Chartmill

COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) Presents a Classic Value Case with High Earnings and Low Valuation ↗

February 04, 2026

Via Chartmill

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

March 25, 2026

Via StockStory

Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million ↗

March 25, 2026

Via The Motley Fool

Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

March 19, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know

March 16, 2026

Via StockStory

3 Healthcare Stocks Walking a Fine Line

March 13, 2026

Via StockStory

Collegium to Present New Real-World Data at PainConnect 2026

March 05, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community

March 03, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Participate in Upcoming Investor Conferences

March 02, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today

February 27, 2026

Via StockStory

Collegium (COLL) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

February 26, 2026

Via StockStory

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

February 26, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect

February 24, 2026

Via StockStory

Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical

February 23, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026

February 12, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

1 Profitable Stock on Our Watchlist and 2 That Underwhelm

February 08, 2026

Via StockStory

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

January 15, 2026

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 ↗

January 14, 2026

Via The Motley Fool

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?

Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.

What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?

Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?

The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market

What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?

The current price of Collegium Pharmaceutical, Inc. - Common Stock is 33.43

When was Collegium Pharmaceutical, Inc. - Common Stock last traded?

The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 04/08/26 04:00 PM ET

What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?

The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.08B

How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?

Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.